GlassScriptPhysician profile
Paul J Vollmar
NPI 1194773671
$5,384.84
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,202 · 2020: $1,427 · 2021: $25.00 · 2022: $1,731.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,755.50 | 2021-2022 | |
| Boston Scientific Corporation | $1,562.21 | 2019-2020 | |
| Arthrex, INC. | $934.50 | 2019 | |
| Gemini Medical LLC | $616.35 | 2019 | |
| Nevro Corp. | $349.79 | 2019-2020 | |
| Abbott Laboratories | $166.49 | 2019-2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Vollmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.